CliffBio
small molecule

HEPARIN SODIUM IN PLASTIC CONTAINER

HEPARIN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameHEPARIN SODIUM IN PLASTIC CONTAINER
Active ingredientHEPARIN SODIUM
Strength5,000 UNITS/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1985
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.